A review article in the April 2015 issue of Gastroenterology looks at the effects of Helicobacter pylori infection and challenges to and benefits of its eradication.

Gastroenterology

A Review of Helicobacter Pylori

A study in the February issue of Gastroenterology looked at mucosal impedance (MI) patterns in patients with GERD and common nonreflux conditions, to assess MI patterns before and after treatment with proton pump inhibitors and to compare performance.

Mucosal Impedance Discriminates GERD from Non-GERD Conditions

A review article in the January issue of Gastroenterology summarizes recent findings and highlights emerging trends in the gut–liver axis relevant to alcoholic liver disease. Dr. Kuemmerle interviews author Dr. Gyongyi Szabo

A Review of Gut–Liver Axis in Alcoholic Liver Disease

A review article in the December issue of Gastroenterology looks at current options and new advances in management of eosinophilic esophagitis. Dr. Kuemmerle speaks with the co-author of this review, Dr. Evan Dellon.

Clinical Management of Eosinophilic Esophagitis

A study in the November issue of Gastroenterology shows results of a controlled randomized trial to compare the efficacy of repeated fecal immunochemical tests (FITs) and colonoscopy in detecting advanced neoplasia in family members of patients w/ CRC.

Comparing Fecal Immunochemical Tests and Colonoscopy in Familial Colorectal Cancer Screening

A study in the October issue of Gastroenterology estimates the risk of upper gastrointestinal bleeding during concomitant use of nonselective (ns)NSAIDs, cyclooxygenase -2 selective inhibitors (COX-2 inhibitors), and low-dose aspirin with other drugs.

Risk of Upper Gastrointestinal Bleeding from Combinations of Drugs

A study in the September issue of Gastroenterology evaluated the effects of vedolizumab induction therapy for patients with Crohn's disease for whom tumor necrosis factor (TNF) antagonists have already failed. Dr. Kuemmerle speaks with Dr. Bruce E. Sands

Vedolizumab for Crohn's Patients After TNF Therapy Has Failed

Two related studies in the August issue of Gastroeneterology discuss factors that could affect colorectal cancer screening strategies, including age, sex, race, ethnicity, and whether or not repeat colonoscopy is advisable within ten years.

Factors That Could Affect Colorectal Cancer Screening Strategies

A study in the July issue of Gastroenterology sheds new light on adverse outcomes associated with drug-induced liver injury. Dr. Kuemmerle speaks with author Dr. Robert J. Fontana

Adverse Outcomes Associated with Drug-Induced Liver Injury

An editorial in the June issue of Gastroenterology discusses recent findings that could help physicians and patients manage celiac disease beyond a gluten-free diet. Dr. Kuemmerle speaks with author Dr. Sheila Crowe.

Managing Celiac Disease Beyond a Gluten-Free Diet

An article in the May issue of Gastroenterology analyzed the UNOS database to determine the impact of the HPS MELD exception policy on outcomes of post-liver transplantation patients. Dr. Kuemmerle speaks with author Dr. David S. Goldberg

Impact of the Hepatopulmonary Syndrome MELD Exception Policy on Outcomes of Patients After Liver Transplantation

An editorial in the April issue of Gastroenterology compares anti-tumor necrosis factor monotherapy with combination therapy for inflammatory bowel disease. Dr. Kuemmerle speaks with co-author Dr. Corey A. Siegel

Anti-Tumor Necrosis Factor Monotherapy vs Combination Therapy for Inflammatory Bowel Disease

A study in the March issue of Gastroenterology examined the safety and efficacy of 2X daily telaprevir in treatment-naive patients with chronic HCV genotype 1 infection, including those with cirrhosis. Dr. Kuemmerle speaks to author Dr. Maria Buti.

Telaprevir Twice Daily Is Noninferior to Telaprevir Every 8 Hours for Chronic Hepatitis C

A study in the February issue of Gastroenterology examined the safety and efficacy of an interferon-free, ribavirin-free regimen of direct-acting antivirals in patients with chronic HCV infection. Dr. Kuemmerle speaks to Dr. Gregory T. Everson.

Efficacy of an Interferon-and-Ribavirin-Free Regimen of Direct-Acting Antivirals in Patients with Chronic HCV Infection

Two studies in the January issue of Gastroenterology show that subcutaneous golimumab induces and maintains clinical response and remission in patients with moderate-to-severe ulcerative colitis; Dr. Kuemmerle speaks to Dr. Brian G. Feagan

Subcutaneous Golimumab Induces and Maintains Clinical Response and Remission in Patients with Moderate-to-Severe Ulcerative Colitis

An engaging, informative mix of author interviews and expert commentary on the latest articles from Gastroenterology, hosted by the AGA journals' online editor, John F. Kuemmerle, MD, AGAF.

hubhopper

Gastroenterology

hubhopper